SCHEMBL13643136

SCHEMBL13643136

CC(Cc1ccc(OCc2ccccc2)c(C(=O)N(C)C)c1)C(=O)OCc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 2/20 0.48
BRD4 O60885 1/20 0.44
LRRK2 Q5S007 2/20 0.44
MAOB P27338 1/20 0.41
FFAR4 Q5NUL3 1/20 0.41
APP P05067 1/20 0.41
PTGER1 P34995 1/20 0.40
PTGER4 P35408 1/20 0.40
PTGER3 P43115 1/20 0.40
PTGER2 P43116 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
POLB P06746 1/20 0.40
LTA4H P09960 1/20 0.40
LAP3 P28838 1/20 0.40
TRPM8 Q7Z2W7 1/20 0.39
EGFR P00533 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14870834 1.00 FOLH1 (0.48) FOLH1BRD4LRRK2MAOBFFAR4
SCHEMBL14870833 0.88 FOLH1 (0.62) FOLH1FFAR4PTGER1PTGER4PTGER3
SCHEMBL13643137 0.88 FOLH1 (0.62) FOLH1FFAR4PTGER1PTGER4PTGER3
SCHEMBL10214905 0.88 FOLH1 (0.47) FOLH1BRD4LRRK2FFAR4APP
SCHEMBL2617285 0.88 FOLH1 (0.47) FOLH1BRD4LRRK2FFAR4APP
SCHEMBL13643141 0.82 S1PR5 (0.53) FOLH1FFAR4PTGER1PTGER4PTGER3
SCHEMBL14870838 0.82 S1PR5 (0.53) FOLH1FFAR4PTGER1PTGER4PTGER3
SCHEMBL10214906 0.80 PTPN1 (0.49) MEN1KMT2AKDM4EPOLBMAPT
SCHEMBL2617283 0.80 PTPN1 (0.49) MEN1KMT2AKDM4EPOLBMAPT
SCHEMBL18082677 0.80 RXRA (0.49) FOLH1FFAR4PTGER1PTGER4PTGER3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120283287-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS QIAN XIANGPING (US) 2012-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120283287-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS KIF5B, KIF2C, PLK1 FOLH1 1919/4885BRD4 780/4885LRRK2 1580/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.